Benign recurrent intrahepatic cholestasis (BRIC) is a rare disorder characterized by recurrent episodes of cholestasis without permanent liver damage. Familial and sporadic cases have been described. Based on existing evidence, both autosomal-recessive and autosomal-dominant inheritance have been co
Treatment of patients with benign recurrent intrahepatic cholestasis
โ Scribed by Johannes Bircher; Charles M. A. Bijleveld; Roel J. Vonk; Folkert Kuipers
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 370 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
S-Adenosylmethionine (800 mg i.v. per day) was used to treat two brothers and a brother and sister from each of two kindreds with benign recurrent intrahepatic cholestasis. Symptoms, routine tests of liver function, concentrations of total bile acids, and the oral clearances of [ 11,12-2H]chenodeoxy
We read with interest the paper by Crosignani and colleagues (1) demonstrating the inefficacy of ursodeoxycholic acid (UDCA) in preventing cholestatic episodes in a patient with benign recurrent intrahepatic cholestasis (BRIC). We would like to report a different experience with a 24-yr-old woman af
Benign recurrent intrahepatic cholestasis (BRIC) is characterized by episodic cholestasis and pruritus without anatomical obstruction. Effective medical treatment is not available. We report complete and long-lasting disappearance of pruritus and normalization of serum bile salt concentrations in ch
have recently provided support for the heterogeneity of this Progressive familial intrahepatic cholestasis (PFIC) is clinical entity, suggesting different causes: clinical, biochemia lethal inherited childhood cholestasis of hepatocellucal, and liver histological features suggest at least two subcat